Emergent Biosolutions Inc (EBS) — Cash Flow-to-Debt Ratio
Emergent Biosolutions Inc (EBS) has a Cash Flow-to-Debt Ratio of 0.10x as of December 2025, meaning its operating cash flow of $77.70 Million could theoretically repay 0% of its total liabilities ($796.00 Million) in one year. See EBS cash flow after capex ratio to measure how efficiently the company converts operating cash flow to free cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Emergent Biosolutions Inc Cash Flow-to-Debt Ratio (2004–2025)
Historical debt coverage capacity for Emergent Biosolutions Inc across 22 annual periods. Also explore Emergent Biosolutions Inc equity growth rate to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for Emergent Biosolutions Inc (2004–2025)
Year-by-year debt coverage analysis for Emergent Biosolutions Inc. For market capitalisation and broader financial context, see EBS company net worth.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.21x | $170.60 Million | $796.00 Million | ▲ +231.1% |
| 2024 | 0.06x | $58.70 Million | $906.90 Million | ▲ +136.8% |
| 2023 | -0.18x | $-206.30 Million | $1.17 Billion | ▼ -819.2% |
| 2022 | -0.02x | $-34.10 Million | $1.78 Billion | ▼ -108.0% |
| 2021 | 0.24x | $321.10 Million | $1.35 Billion | ▼ -36.2% |
| 2020 | 0.37x | $536.90 Million | $1.44 Billion | ▲ +146.3% |
| 2019 | 0.15x | $188.00 Million | $1.24 Billion | ▲ +342.4% |
| 2018 | 0.03x | $41.80 Million | $1.22 Billion | ▼ -97.4% |
| 2017 | 1.32x | $208.14 Million | $157.86 Million | ▲ +821.7% |
| 2016 | 0.14x | $53.49 Million | $373.91 Million | ▲ +23.4% |
| 2015 | 0.12x | $44.46 Million | $383.57 Million | ▼ -59.5% |
| 2014 | 0.29x | $112.32 Million | $392.06 Million | ▼ -59.4% |
| 2013 | 0.71x | $96.97 Million | $137.47 Million | ▲ +117.3% |
| 2012 | 0.32x | $39.64 Million | $122.10 Million | ▲ +189.5% |
| 2011 | 0.11x | $14.59 Million | $130.14 Million | ▼ -85.7% |
| 2010 | 0.79x | $99.54 Million | $126.76 Million | ▲ +159.6% |
| 2009 | 0.30x | $30.51 Million | $100.87 Million | ▲ +278.0% |
| 2008 | 0.08x | $7.32 Million | $91.44 Million | ▼ -85.2% |
| 2007 | 0.54x | $55.45 Million | $102.35 Million | ▲ +1431.1% |
| 2006 | -0.04x | $-4.06 Million | $99.78 Million | ▼ -103.9% |
| 2005 | 1.04x | $42.25 Million | $40.59 Million | ▲ +421.8% |
| 2004 | 0.20x | $9.20 Million | $46.11 Million | — |